Early in the treatment process, a reduction in the proportion of tumor cells expressing HER3 on the membrane was observed, possibly due to the treatment reducing the number of HER3-expressing tumor cells or the binding and internalization of the HER3/HER3-DXd complex. Here, ERBB3 is linked to neoplasm.